Cari,
ho scritto alla Cosmopharma e questa è la risposta in merito al cb 03 01
Dear Mr. xxx,
I am glad to inform you that Phase II US clinical study on acne vulgaris (NCT01631474) started as planned on June 2012, and it is proceeding regularly.
A previous Phase II European study in...